Similar articles

• Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin.

  Slaga TJ, Gleason GL, DiGiovanni J, Sukumaran KB, Harvey RG. Slaga TJ, et al. Cancer Res. 1979 Jun;39(6 Pt 1):1934-6. Cancer Res. 1979. PMID: 109189
• Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives.

  Wislocki PG, Gadek KM, Chou MW, Yang SK, Lu AY. Wislocki PG, et al. Cancer Res. 1980 Oct;40(10):3661-4. Cancer Res. 1980. PMID: 6777036 No abstract available.
• Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes.

  Wood AW, Levin W, Chang RL, Conney AH, Slaga TJ, O'Malley RF, Newman MS, Buhler DR, Jerina DM. Wood AW, et al. J Natl Cancer Inst. 1982 Sep;69(3):725-8. J Natl Cancer Inst. 1982. PMID: 6810009
• Biotransformation and bioactivation of 7, 12-dimethylbenz[a]anthracene (7, 12-DMBA).

  DiGiovanni J, Juchau MR. DiGiovanni J, et al. Drug Metab Rev. 1980;11(1):61-101. doi: 10.3109/03602538008994022. Drug Metab Rev. 1980. PMID: 6775921 Review.
• The action of the initiating agent in epidermal carcinogenesis.

  Ritchie AC. Ritchie AC. Proc Can Cancer Conf. 1966;6:176-85. Proc Can Cancer Conf. 1966. PMID: 5972979 Review. No abstract available.